2 innovative scientific platforms

Ipsen has built two leading-edge technological platforms, toxins and peptides, fields in which we stand out for our acknowledged expertise. This specialist knowledge also opens the door to the possibility of harnessing the synergies in toxins and peptides in hybrid molecules like targeted secretion inhibitors (TSI). With their unique properties, these molecules offer potential in the treatment of neuromuscular, endocrine and proliferative disorders, as well as for pain.


excellent technological platforms: toxins and peptides


of sales invested in R&D in 2015

Last update 13/04/2017